DOI:
10.1055/s-00031934
The Journal of Hip Surgery
LinksClose Window
References
Makarowski W, Zhao WW, Bevirt T, Recker DP.
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
Osteoarthritis Cartilage 2002;
10 (04) 290-296
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.